These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2507515)

  • 21. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of attention deficit and borderline personality disorders with psychostimulants: case report.
    Hooberman D; Stern TA
    J Clin Psychiatry; 1984 Oct; 45(10):441-2. PubMed ID: 6480572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children.
    Rapport MD; DuPaul GJ; Kelly KL
    Psychopharmacol Bull; 1989; 25(2):285-90. PubMed ID: 2602521
    [No Abstract]   [Full Text] [Related]  

  • 26. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
    Wigal SB; Wilens TE; Wolraich M; Lerner M
    Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does haloperidol block methylphenidate?
    Taylor E
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):804. PubMed ID: 2793811
    [No Abstract]   [Full Text] [Related]  

  • 31. Pemoline and lithium in a patient with attention deficit disorder.
    Brown RP; Ingber PS; Tross S
    J Clin Psychiatry; 1983 Apr; 44(4):146-8. PubMed ID: 6403515
    [No Abstract]   [Full Text] [Related]  

  • 32. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
    Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features.
    Klorman R; Brumaghim JT; Salzman LF; Strauss J; Borgstedt AD; McBride MC; Loeb S
    J Abnorm Psychol; 1988 Nov; 97(4):413-422. PubMed ID: 3060506
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral medications for minimal brain dysfunction in children.
    Green RP; Scales SM; Rosser PL
    J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677
    [No Abstract]   [Full Text] [Related]  

  • 36. Lithium-induced nephrotic syndrome in a prepubertal boy.
    Petersen CE; Amaral S; Frosch E
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):210-3. PubMed ID: 18439118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
    McDaniel KD
    Clin Pediatr (Phila); 1986 Feb; 25(2):65-71. PubMed ID: 2417773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of methylphenidate.
    Haddock ST
    N Engl J Med; 1972 Feb; 286(7):375. PubMed ID: 5008562
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of antidepressants in the treatment of children with behaviour disorders.
    Huessy HR
    Can J Psychiatry; 1993 Feb; 38(1):68-9. PubMed ID: 8448727
    [No Abstract]   [Full Text] [Related]  

  • 40. Methylphenidate and minimal brain dysfunction.
    Cohn HD
    N Engl J Med; 1971 Nov; 285(20):1150. PubMed ID: 5095752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.